Log in to search using one of your social media accounts:

 

Breast cancer scandal may have cost 270 lives due to computer error
Up to 270 women in England may have died because they were not called for a final breast cancer screening, the British government disclosed on Wednesday. (Source: CNN.com - Health)
Source: CNN.com - Health - May 2, 2018 Category: Consumer Health News Source Type: news

Breast cancer screening guidelines: Should you be screened by the NHS?
A HUGE error in breast cancer screenings may have caused the deaths of hundreds of British women, Jeremy Hunt has said. But should you be screened by the NHS? What is the advice being given? Here is what you need to know. (Source: Daily Express - Health)
Source: Daily Express - Health - May 2, 2018 Category: Consumer Health News Source Type: news

UK breast cancer scandal affected 450,000 women, may have cost 270 lives
Up to 270 women in England may have died because they were not called for a final breast cancer screening, the British government disclosed on Wednesday. (Source: CNN.com - Health)
Source: CNN.com - Health - May 2, 2018 Category: Consumer Health News Source Type: news

UK: 450,000 women missed out on breast cancer test
Britain's health minister has apologized for what he called a "serious failure" that resulted in hundreds of thousands of women not being invited to their final screening test for breast cancer (Source: ABC News: Health)
Source: ABC News: Health - May 2, 2018 Category: Consumer Health News Tags: Health Source Type: news

Breast cancer screening scandal: How many women have been affected by NHS 'failure'?
A BREAST cancer screening failure was revealed to the House of Commons by Jeremy Hunt today. The failure means up to 270 women have had their lives ‘shortened’ after they did not receive an invitation to attend a screening for the signs and symptoms of the disease. (Source: Daily Express - Health)
Source: Daily Express - Health - May 2, 2018 Category: Consumer Health News Source Type: news

UK: 450,000 women missed out on breast cancer test
Britain's health minister has apologized for what he called a "serious failure" that resulted in hundreds of thousands of women not being invited to their final screening test for breast cancer (Source: ABC News: Health)
Source: ABC News: Health - May 2, 2018 Category: Consumer Health News Tags: Health Source Type: news

Updated: Hunt launches review after 450,000 breast screenings missed due to IT failure
More than 400,000 women missed their final routine breast cancer screening over nearly a decade because of an IT failure, Jeremy Hunt said today. (Source: HSJ)
Source: HSJ - May 2, 2018 Category: UK Health Source Type: news

Hunt launches review after 450,000 breast screenings missed due to IT failure
More than 400,000 women missed their final routine breast cancer screening over nearly a decade because of an IT failure, Jeremy Hunt said today. (Source: HSJ)
Source: HSJ - May 2, 2018 Category: UK Health Source Type: news

Breast cancer screening failure may have shortened 270 lives in England
LONDON (Reuters) - As many as 270 women's lives may have been shortened after an IT failure in England's breast cancer screening program meant 450,000 patients were not invited for appointments, Britain's health minister said on Wednesday. (Source: Reuters: Health)
Source: Reuters: Health - May 2, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Breast cancer screening age: How old should you be to have NHS cancer screening?
BREAST CANCER screening appointment letters were not sent to thousands of women and the NHS computer glitch is now the subject of a major government enquiry. How old should you be to have NHS cancer screening? (Source: Daily Express - Health)
Source: Daily Express - Health - May 2, 2018 Category: Consumer Health News Source Type: news

Komen Race for the Cure aiming for $1.5M raised this year
The Susan G. Komen Columbus Race for the Cure is hoping to have a record-setting year as the largest race in the country raising money to beat breast cancer. Local businesses such as L Brands, Cameron Mitchell Restaurants, Big Lots and others are sponsoring the event that is anticipating more than 25,000 participants downtown on May 19. This year, the event hopes to generate $1.5 million in funding for breast cancer research and support for patients. "75 percent of the money we make goes to fund… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 2, 2018 Category: Pharmaceuticals Authors: Emily Bench Source Type: news

Hunt pledges advice for GPs after 450,000 women denied breast screening
Health secretary Jeremy Hunt has pledged to provide guidance to GPs after informing parliament that 450,000 women were denied screening for breast cancer over the past decade due to an IT error. (Source: GP Online News)
Source: GP Online News - May 2, 2018 Category: Primary Care Tags: Cancer Source Type: news

Breast cancer places greater financial burden on black women
(UNC Lineberger Comprehensive Cancer Center) Having breast cancer placed a significantly greater financial strain on black women than white women, according to study at the University of North Carolina Lineberger Comprehensive Cancer Center. A survey of women who were diagnosed with breast cancer in North Carolina between 2008 and 2013 found that two years after a diagnosis, 58 percent of black women reported a negative financial impact of cancer, compared with 39 percent of white women. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 2, 2018 Category: Cancer & Oncology Source Type: news

Let's get physical: Breast cancer survivors on the move
(University of British Columbia Okanagan campus) Physical activity is an effective way to help improve the many mental and physical side effects of breast cancer treatment. Yet, studies show up to 70 per cent of breast cancer survivors are not getting enough activity. This may be about to change thanks to new research from UBC's Okanagan campus that demonstrates that financial support and incentives are effective in increasing physical activity among breast cancer survivors. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 2, 2018 Category: International Medicine & Public Health Source Type: news

Hunt admits failure of breast screening programme may have ‘shortened’ 270 lives
Jeremy Hunt has told parliament that failures in the national breast screening programme may have shortened the lives of 270 women with breast cancer. (Source: NHS Networks)
Source: NHS Networks - May 2, 2018 Category: UK Health Source Type: news

Advanced 3D models improve breast cancer detection
An EU-funded project is developing advanced three-dimensional computational and physical models of breast tumours, providing the medical community with powerful new instruments to tackle breast cancer. The initiative will reveal the possibilities for improved diagnostic techniques for detecting a disease that affects one in eight women in Europe at some point in their lives. (Source: EUROPA - Research Information Centre)
Source: EUROPA - Research Information Centre - May 2, 2018 Category: Research Source Type: news

Agendia's MammaPrint(R) Receives Positive Coverage Decisions from Three Major Private Healthcare Insurers
Decisions from Aetna, Cigna and UnitedHealthcare followed the latest update to the American Society of Clinical Oncology (ASCO) guidelines recommending MammaPrint® Breast Cancer Risk of Recurrence Test for certain breast cancer patients Majority of ... Diagnostics, Personalized Medicine, Oncology, Reimbursement Agendia, MammaPrint (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 1, 2018 Category: Pharmaceuticals Source Type: news

Pill lights up breast cancer in test with mice, may improve disease diagnosis
A pill that makes tumors light up when exposed to infrared light could more effectively help diagnose breast cancer, according to a study with mice. (Source: Health News - UPI.com)
Source: Health News - UPI.com - May 1, 2018 Category: Consumer Health News Source Type: news

JAMA: Women need to be aware of mammography's harms
Screening mammography can save lives but also lead to harms such as false positives...Read more on AuntMinnie.comRelated Reading: Does double reading improve breast cancer screening? DBT improves breast cancer screening in young women Less isn't always more with breast screening recall rate 2018 budget bill includes mammography protections Mammography finds more cancers in younger women (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 1, 2018 Category: Radiology Source Type: news

Medical News Today: Breast cancer: Innovative pill may aid diagnosis
Many cases of breast cancer are either misdiagnosed or remain undetected, due to the unclear nature of some tumors. Could a pill solve this problem? (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 1, 2018 Category: Consumer Health News Tags: Breast Cancer Source Type: news

Computers Equal Radiologists in Assessing Breast Density and Associated Breast Cancer Risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic. Both assessment methods were equally accurate in predicting both the risk of cancer detected through mammography screening and the risk of interval invasive cancer - that is, cancer diagnosed within a year of a negative mammography result. (Source: eHealth News EU)
Source: eHealth News EU - May 1, 2018 Category: Information Technology Tags: Featured Research Research and Development Source Type: news

Automated breast density assessment informs cancer risk
Can software that calculates breast density perform as well as a radiologist...Read more on AuntMinnie.comRelated Reading: Wis. enacts breast density law Is screening breast MRI being used in the wrong women? Cancer history in relatives boosts breast cancer risk Deep-learning algorithm can assess breast density Breast density laws mystify primary care providers (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 1, 2018 Category: Radiology Source Type: news

Making individualized choices about breast cancer screening
(Brigham and Women's Hospital) The authors note, that despite the fact that the United States Preventive Services Task Force (USPSTF) changed its recommendation in 2009 to mammograms every two years for women aged 50-74 instead of annual mammograms beginning at age 40, there has been little change in US screening practices. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 1, 2018 Category: Cancer & Oncology Source Type: news

New lab study reveals how breast cancer drug can accelerate cancer cell growth
(The Francis Crick Institute) The breast cancer drug lapatinib which is designed to shrink tumors can sometimes cause them to grow in the lab, according to a new study. By understanding the molecular basis of this phenomenon, scientists hope that their findings will lead to safer treatment decision-making and drug design in the future. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 1, 2018 Category: Cancer & Oncology Source Type: news

VEGF-neuropilin-2 signaling promotes stem-like traits in breast cancer cells by TAZ-mediated repression of the Rac GAP {beta}2-chimaerin
The role of vascular endothelial growth factor (VEGF) signaling in cancer is not only well known in the context of angiogenesis but also important in the functional regulation of tumor cells. Autocrine VEGF signaling mediated by its co-receptors called neuropilins (NRPs) appears to be essential for sustaining the proliferation and survival of cancer stem cells (CSCs), which are implicated in mediating tumor growth, progression, and drug resistance. Therefore, understanding the mechanisms involved in VEGF-mediated support of CSCs is critical to successfully treating cancer patients. The expression of the Hippo effector TAZ ...
Source: Signal Transduction Knowledge Environment - May 1, 2018 Category: Science Authors: Elaimy, A. L., Guru, S., Chang, C., Ou, J., Amante, J. J., Zhu, L. J., Goel, H. L., Mercurio, A. M. Tags: STKE Research Articles Source Type: news

New Model Can Assess Breast Cancer Risk in Women With Atypical Hyperplasia
Researchers have developed a new model to help predict the development of breast cancer in women with atypical hyperplasia based on a breast biopsy. (Source: CancerNetwork)
Source: CancerNetwork - April 30, 2018 Category: Cancer & Oncology Authors: Dave Levitan Tags: Breast Cancer SiteTerms/www.cannabissciencetech.com/News Source Type: news

Similar Risk Predicted for Automated, Clinical BI-RADS Density
MONDAY, April 30, 2018 -- Automated and clinical Breast Imaging Reporting and Data System (BI-RADS) density measures similarly predict breast cancer risk, according to a study published online May 1 in the Annals of Internal Medicine. Karla... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 30, 2018 Category: Pharmaceuticals Source Type: news

Doctor shares myth-busting truths about breast cancer
Dr. Kristi Funk shares her tips in her new book, "Breasts: The Owner's Manual." (Source: ABC News: Health)
Source: ABC News: Health - April 30, 2018 Category: Consumer Health News Tags: GMA Source Type: news

Breast cancer: Potential new treatment for aggressive form of the cancer
BREAST cancer sufferers may be twice as likely to benefit from a drug used to treat ovarian cancer, says a groundbreaking study out today set to change international clinical guidelines. (Source: Daily Express - Health)
Source: Daily Express - Health - April 30, 2018 Category: Consumer Health News Source Type: news

Breast cancer treatment: Potential new treatment for aggressive form of the cancer
BREAST cancer sufferers may be twice as likely to benefit from a drug used to treat ovarian cancer, says a groundbreaking study out today set to change international clinical guidelines. (Source: Daily Express - Health)
Source: Daily Express - Health - April 30, 2018 Category: Consumer Health News Source Type: news

PARP Drugs Help Some Breast Cancer Patients, But They're No Magic Bullet
For patients with metastatic breast cancer, doctors don ’t yet know how to predict long-term responses to this PARP drug. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 30, 2018 Category: Pharmaceuticals Authors: Elaine Schattner, Contributor Tags: NYSE:AZN NYSE:PFE Source Type: news

PARP Drugs Help Some Metastatic Breast Cancer Patients, But They're No Magic Bullet
Lynparza is a pill, usually taken twice daily. It ’s convenient and generally well-tolerated. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 30, 2018 Category: Pharmaceuticals Authors: Elaine Schattner, Contributor Tags: NYSE:AZN NYSE:PFE Source Type: news

Beverley Craven: 'I’ll never get over losing my sister to cancer'
MOST of us have been affected by cancer but for Beverley Craven it has been an uncomfortably close and continuing encounter. The singer, now 54, won her own battle with breast cancer but she lost her sister and a cousin to the disease when they were in their 40s. (Source: Daily Express - Health)
Source: Daily Express - Health - April 30, 2018 Category: Consumer Health News Source Type: news

WATCH: Renowned breast cancer surgeon Dr. Kristi Funk opens up about her new book
The doctor discusses the major takeaways from her new book, "Breasts: the Owner's Manual: Every Woman's Guide to Reducing Cancer Risk, Making Treatment Choices, and Optimizing Outcomes." (Source: ABC News: Health)
Source: ABC News: Health - April 30, 2018 Category: Consumer Health News Tags: GMA Source Type: news

Breast Cancer Risk and Tamoxifen Use
Only 1 in 7 Women at Risk for Breast Cancer Take Tamoxifen (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - April 30, 2018 Category: General Medicine Source Type: news

Computers equal radiologists in assessing breast density and associated breast cancer risk
(University of California - San Francisco) Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 30, 2018 Category: Cancer & Oncology Source Type: news

Targeting chemotherapy with genetic testing benefits women with aggressive breast cancer
(Institute of Cancer Research) Women with an aggressive form of breast cancer who have faults in their BRCA genes do much better on chemotherapy drug carboplatin than standard treatment, a major clinical trial reports. Researchers found that women with advanced 'triple-negative' breast cancer who had inherited a BRCA mutation were twice as likely to benefit from carboplatin as docetaxel, which is currently standard of care for these patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 30, 2018 Category: Cancer & Oncology Source Type: news

Magnetic nanoparticles leap from lab bench to breast cancer clinical trials
(DOE/Sandia National Laboratories) A long-standing collaboration between Sandia National Laboratories and Imagion Biosystems produced precise magnetic nanoparticles for a breast cancer clinical trial later this year. The nanoparticles stick to breast cancer cells, allowing the detection and removal of even small metastases. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 30, 2018 Category: International Medicine & Public Health Source Type: news

Pill for breast cancer diagnosis may outperform mammograms
(University of Michigan) As many as one in three women treated for breast cancer undergo unnecessary procedures, but a new method for diagnosing it could do a better job distinguishing between benign and aggressive tumors. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 30, 2018 Category: International Medicine & Public Health Source Type: news

Getting off opioids with medical marijuana: Patients turn to pot over pills
In 2016, opioids killed more Americans than breast cancer. The drug overdose epidemic has become one of the most concerning public health issues of recent time, and in an effort to stem the tide, moreg and more patients and doctors are turning to pot over pills. (Source: CNN.com - Health)
Source: CNN.com - Health - April 29, 2018 Category: Consumer Health News Source Type: news

One woman's journey to find a spa that would admit her despite industry wide health fear myths
My best medicine has always been a day of pampering. Until, that is, December 2016, when I was diagnosed with breast cancer and my body suddenly became unworthy. (Source: the Mail online | Health)
Source: the Mail online | Health - April 28, 2018 Category: Consumer Health News Source Type: news

4 Trends Advancing Medtech
For the past 20 years, the Medical Design Excellence Awards have celebrated medical products that improve the quality and accessibility of healthcare. Our finalists this year carry on this tradition, while also keeping in step with today’s high-tech digital and consumer trends. With the help of our esteemed jurors, we have identified four key trends in this year’s group of finalists: risk reduction; faster, more-efficient healthcare delivery; the influence of the Internet of Things; and the consumerization of healthcare. We’ve been tracking a few of these trends in past awards programs, so they’re n...
Source: MDDI - April 27, 2018 Category: Medical Devices Authors: Daphne Allen Tags: MD & M East (New York) Design Source Type: news

Breast Cancer and African Ancestry
In this video, Dr. Melissa Davis explains how African ancestry may play a role in breast cancer, and ways that genetics might be used to help guide treatment. (Source: CancerNetwork)
Source: CancerNetwork - April 27, 2018 Category: Cancer & Oncology Authors: Melissa Davis, PhD Tags: Conferences/AACR Street Team Breast Cancer News Source Type: news

Only 1 in 7 Women at Risk for Breast Cancer Take Tamoxifen Only 1 in 7 Women at Risk for Breast Cancer Take Tamoxifen
A small study in the UK has found 6 of 7 women with a family history of breast cancer opted out of taking tamoxifen as a preventive measure.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 27, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

CHMP recommends EU approval of Roche ’s Perjeta for post-surgery treatment of HER2-positive early breast cancer at high risk of recurrence
Roche today announced the European Medicines Agency ’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Perjeta® (pertuzumab) in combination with Herceptin® (trastuzumab) and chemotherapy (the Perjeta-based regimen) for post-surgery (adjuvant) treatment of adult patients with HER2-positive early breast c ancer (eBC) at high risk of recurrence. (Source: Roche Media News)
Source: Roche Media News - April 27, 2018 Category: Pharmaceuticals Source Type: news

CHMP recommends EU approval of Roche ’s Perjeta for post-surgery treatment of HER2-positive early breast cancer at high risk of recurrence
Roche today announced the European Medicines Agency ’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Perjeta® (pertuzumab) in combination with Herceptin® (trastuzumab) and chemotherapy (the Perjeta-based regimen) for post-surgery (adjuvant) treatment of adult patients with HER2-positive early breast c ancer (eBC) at high risk of recurrence. (Source: Roche Investor Update)
Source: Roche Investor Update - April 27, 2018 Category: Pharmaceuticals Source Type: news

CHMP recommends EU approval of Roche ’s Perjeta for post-surgery treatment of HER2-positive early breast cancer at high risk of recurrence
Roche today announced the European Medicines Agency ’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Perjeta® (pertuzumab) in combination with Herceptin® (trastuzumab) and chemotherapy (the Perjeta-based regimen) for post-surgery (adjuvant) treatment of adult patients with HER2-positive early breast c ancer (eBC) at high risk of recurrence. (Source: Roche Media News)
Source: Roche Media News - April 27, 2018 Category: Pharmaceuticals Source Type: news

Breast Cancer Genes a Real Risk for Men, Too
Title: Breast Cancer Genes a Real Risk for Men, TooCategory: Health NewsCreated: 4/26/2018 12:00:00 AMLast Editorial Review: 4/27/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - April 27, 2018 Category: Cancer & Oncology Source Type: news

ARRS: Screening mammography is effective in younger women
Screening mammography in women ages 40 to 49 finds almost 20% more cancers...Read more on AuntMinnie.comRelated Reading: How serious is the risk of breast cancer overdiagnosis? DBT improves breast cancer screening in young women Mammography finds more cancers in younger women SABCS: Biannual breast MRI best for young women at high risk DBT in younger women mitigates mammography's 'harms' (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 27, 2018 Category: Radiology Source Type: news